Clinical Trial Update: APC-231 Once a Day (QD) for 7 Days vs. Penicillin Taken Four Times a Day (QID) in Pediatric Patients With Strep Throat [Phase 3]

View source ↗

Summary

The document reports the completion of a Phase 3 study comparing APC-231 given once daily for 7 days versus penicillin given four times daily in pediatric patie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Streptococcal Pharyngitis

Drugs mentioned

• APC-231

Snippet

Sponsor: Advancis Pharmaceutical Corporation | Conditions: Pharyngitis | Phase 3 | Status: COMPLETED